Hokkaido University Collection of Scholarly and Academic Papers >
Theses >
博士 (生命科学) >
Unnatural MUC1 based glycopeptides in early stage breast cancer biomarkers discovery
Files in This Item:
|
|
Related Items in HUSCAP:
|
Title: | Unnatural MUC1 based glycopeptides in early stage breast cancer biomarkers discovery |
Other Titles: | 非天然型 MUC1糖ペプチドによる乳がん早期バイオマーカーの探索 |
Authors: | Guillén Poza, Pablo Adrián Browse this author |
Issue Date: | 25-Mar-2021 |
Publisher: | Hokkaido University |
Abstract: | Mucin 1 (MUC1) is a highly glycosylated O-glycoprotein that experiences alterations
in cancer cells and assists the tumor progression. In many human carcinomas and, in
particular in breast cancer, MUC1 is overexpressed and aberrantly glycosylated. As a
consequence, previously covered antigens are now exposed and accessible to the immune
system. This results in the production of antibodies towards these neoepitopes, providing an
exploitable divergence between healthy individuals and cancer patients antibody profiles. In
order to properly differentiate and develop specific diagnostic tools for early breast cancer
detection, we require of the appropriate chemical probes.
In this thesis, we have focused on the MUC1 tumor-associated carbohydrate Tn
antigen (α-O-GalNAc-Ser/Thr) because of its tumor high specificity, well-defined chemical
structure and starting point role for more complex tumor antigens. Previous studies report the
use of autoantibodies as potential cancer biosensors. With the intention of developing a more
effective and robust sensing device we considered the substitution of GalNAc
monosaccharides by stable glycomimic units. To investigate our hypothesis, two different
glycopeptide libraries presenting the natural Tn antigen or the sp2-iminosugar-derived
unnatural analog were produced through microwave assisted solid-phase peptide synthesis.
The whole glycopeptide collection was then evaluated with anti-MUC1 (SM3, VU-3C6, and
VU-11E2) monoclonal antibodies (mAbs) in a microarray platform. The most promising
candidates were tested with healthy, stage I and stage IV breast cancer sera with the aim of
discovering serological autoantibodies (autoAbs) as stage-dependent breast cancer diagnostic
biomarkers.
Despite the variability between mAbs, the suitability of the glycopeptides bearing the
unnatural sp2-iminosugar-based Tn antigen mimic to detect anti-MUC1 antibodies was
demonstrated. The present results also revealed that the glycopeptide mimic-antibody
interactions are glycosylation pattern-specific and underlined the crucial contribution of the
PDTR epitope embedded in the glycopeptide backbone to mAbs binding. Furthermore,
stage I breast cancer serum experiments clearly showed autoAbs binding with a specific sp2-iminosugar
glycopeptide with almost no interaction with healthy serum, results which will
promote further studies on their function as early cancer biomarkers. |
Description: | 担当:理学部図書室 |
Conffering University: | 北海道大学 |
Degree Report Number: | 甲第14391号 |
Degree Level: | 博士 |
Degree Discipline: | 生命科学 |
Examination Committee Members: | (主査) 教授 西村 紳一郎, 教授 門出 健次, 教授 比能 洋, 客員准教授 Garcia Martin Fayna Maria(先端生命科学研究院) |
Degree Affiliation: | 生命科学院(生命科学専攻) |
Type: | theses (doctoral) |
URI: | http://hdl.handle.net/2115/82016 |
Appears in Collections: | 課程博士 (Doctorate by way of Advanced Course) > 生命科学院(Graduate School of Life Science) 学位論文 (Theses) > 博士 (生命科学)
|
|